Ditchcarbon
  • Contact
  1. Organizations
  2. Alfresa Holdings
Public Profile
Pharmaceutical Preparation Manufacturing
JP
updated 2 months ago

Alfresa Holdings Sustainability Profile

Company website

Alfresa Holdings Corporation, commonly referred to as Alfresa, is a prominent player in the pharmaceutical distribution and healthcare industry, headquartered in Japan. Established in 2003, the company has rapidly expanded its operations across Asia, focusing on the distribution of pharmaceuticals, medical devices, and healthcare products. Alfresa is renowned for its commitment to quality and innovation, offering a diverse range of core services that include logistics, supply chain management, and pharmaceutical wholesaling. The company’s unique approach to integrating advanced technology in its operations has positioned it as a leader in the market. With a strong emphasis on customer satisfaction and a robust network of partnerships, Alfresa has achieved significant milestones, solidifying its reputation as a trusted provider in the healthcare sector. Its dedication to improving healthcare access and outcomes continues to drive its success in the competitive landscape.

DitchCarbon Score

How does Alfresa Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

43

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Alfresa Holdings's score of 43 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

62%

Let us know if this data was useful to you

Alfresa Holdings's reported carbon emissions

In 2024, Alfresa Holdings reported total carbon emissions of approximately 32,904,000 kg CO2e for Scope 1 and about 38,939,000 kg CO2e for Scope 2, resulting in a combined total of around 71,843,000 kg CO2e. This marks a slight increase from 2023, where emissions were approximately 32,399,000 kg CO2e for Scope 1 and about 36,683,000 kg CO2e for Scope 2, totalling around 69,082,000 kg CO2e. Alfresa Holdings has set ambitious climate commitments, aiming for a 10% reduction in CO2 emissions by the end of FY2024 and a 30% reduction by the end of FY2030, using FY2020 emissions as a baseline. The company is also committed to achieving carbon neutrality by 2050, encompassing all scopes of emissions. The emissions data is not cascaded from any parent organization, and all figures are reported directly by Alfresa Holdings Corporation. The company continues to focus on initiatives that will help meet these reduction targets and contribute to its long-term sustainability goals.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201320192021202220232024
Scope 1
-
-
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
-
-
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-
-

How Carbon Intensive is Alfresa Holdings's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Alfresa Holdings's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Alfresa Holdings's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Alfresa Holdings is in JP, which has a low grid carbon intensity relative to other regions.

Alfresa Holdings's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Alfresa Holdings has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Alfresa Holdings's Emissions with Industry Peers

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Astellas

JP
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Otsuka Pharmaceutical Co., Ltd.

JP
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251105.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy